Professional Documents
Culture Documents
Drug Study
Drug Study
Valles
BSN-III
Drug Study
Name of Drugs and
Classification
Broncaire Expectorant
(Antiasthmatic & COPD
Preparations)
Indication
Mechanism of Action
Dosage
Adverse Reaction
Asmacaire
(Antiasthmatic & COPD
Preparations)
2.5ml
Nursing Consideration
Assessment:
feelings of tension
peripheral vasodilation
Assess patient for previous sensitivity
headaches
reaction to
Assess patient for signs and
symptoms of infection including
characteristics of wounds, sputum,
urine, and stool.
Implementation:
Give deeply in large muscle mass
Shake medication before
administering.
Tremors
Use minimal doses for minimal
Nervousness
periods; drug tolerance can occur
Nausea
with prolonged use.
Vomiting
Maintain a beta-adrenergic blocker
Tachycardia
(cardioselective beta-blocker, such as
Palpitations
atenolol, should be used with
respiratory distress) on standby in
case cardiac arrhythmias occur.
Prepare solution for inhalation by
diluting 0.5 mL 0.5% solution with
2.5 mL normal saline; deliver over 5
15 min by nebulization.
Do not exceed recommended dosage;
administer pressurized inhalation
drug forms during second half of
inspiration, because the airways are
open wider and the aerosol
distribution is more extensive.